12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·10/28/2025 17:06:24
Listen to the news
Gainers
- VSee Health (NASDAQ:VSEE) shares moved upwards by 134.8% to $1.45 during Tuesday's regular session. The company's market cap stands at $10.5 million.
- Pulmonx (NASDAQ:LUNG) stock moved upwards by 56.41% to $2.44. The company's market cap stands at $62.0 million.
- Arcutis Biotherapeutics (NASDAQ:ARQT) shares moved upwards by 30.08% to $25.55. The company's market cap stands at $2.3 billion. As per the press release, Q3 earnings came out today.
- ALT5 Sigma (NASDAQ:ALTS) stock moved upwards by 20.42% to $2.72. The company's market cap stands at $281.7 million.
- National Research (NASDAQ:NRC) stock moved upwards by 19.0% to $13.59. The company's market cap stands at $263.3 million. As per the news, the Q3 earnings report came out yesterday.
- Nanobiotix (NASDAQ:NBTX) stock increased by 18.73% to $17.91. The market value of their outstanding shares is at $727.0 million.
Losers
- Co-Diagnostics (NASDAQ:CODX) stock decreased by 53.4% to $0.59 during Tuesday's regular session. The company's market cap stands at $60.6 million.
- Aditxt (NASDAQ:ADTX) stock fell 45.78% to $0.11.
- Wellgistics Health (NASDAQ:WGRX) shares decreased by 21.78% to $0.64. The market value of their outstanding shares is at $74.9 million.
- Jyong Biotech (NASDAQ:MENS) stock fell 20.6% to $39.7. The market value of their outstanding shares is at $3.8 billion.
- Genprex (NASDAQ:GNPX) shares decreased by 20.29% to $6.97. The company's market cap stands at $8.7 million.
- Edesa Biotech (NASDAQ:EDSA) shares decreased by 19.25% to $2.12. The company's market cap stands at $19.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.